Pfau, M

[Correction for: Switching Therapy from Ranibizumab and/or Bevacizumab to Aflibercept in Neovascular Age-Related Macular Degeneration (AMD): One-Year Results]. [electronic resource] - Klinische Monatsblatter fur Augenheilkunde 08 2016 - e3 p. digital

Publication Type: Journal Article; Published Erratum

1439-3999

10.1055/s-0042-115798 doi